Sort
51,593 grants matching “hepatitis”
Type I interferon-stimulated genes and the antiviral immune response
$397,150Charles M. Rice · Rockefeller University · R01 · FY2013 · AI
Cognitive and Inflammation Targeted Gut-Brain Interventions in People Living with HIV who are High-Risk Alcohol Users
$397,106Eric Porges · University Of Florida · P01 · FY2024 · AA
FINR: A Novel Modulator of Insulin Signaling
$397,092Salk Institute For Biological Studies · R01 · FY2004 · DK
Drug Therapies Identified through Modeling AT Deficiency in C Elegans
$397,080Gary Arthur Silverman · Washington University · P01 · FY2023 · DK
University of Pittsburgh MACS/WIHS CCS- Supplement Funds from NHLBI
$397,060Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · HL
2/4-American Consortium of Early Liver Transplantation-Prospective Alcohol-associated liver disease Cohort Evaluation (ACCELERATE-PACE)
$397,049Marina Serper · University Of Pennsylvania · R01 · FY2025 · AA
Computational discovery of effective hepatitis C intervention strategies
$397,037Harel Dahari · Loyola University Chicago · R01 · FY2018 · GM
Action Plans & Memory Consolidation: Reducing HIV Risk in Drug Users
$397,018Alan W Stacy · Claremont Graduate University · R01 · FY2015 · DA
Systemic delivery of an oncolytic adenovirus targeting TGFβ to enhance anti-PD-1 and anti-CTLA-4 therapy for triple negative breast cancer
$396,958Weidong Xu · Endeavor Health Clinical Operations · R01 · FY2024 · CA
ECHO-F Model to Expand Medication Assisted Treatment in Rural Primary Care
$396,955Julie G. Salvador · University Of New Mexico Health Scis Ctr · R18 · FY2017 · HS
A Precision Medicine Tool for Optimal Personalized Treatment in Patients with Acute Myeloid Leukemia
$396,908Athanasios Mantalaris · Sanicka, Inc · R42 · FY2022 · CA
Hepatitis C Virus-Developing Antivirals and Vaccines
$396,857Rockefeller University · R01 · FY2005 · CA
Working with HIV clinics to adopt addiction treatments using Implementation Facilitation (WHAT IF?)
$396,853David Fiellin · Yale University · R01 · FY2015 · DA
Role of Wnt/Beta-Catenin Signaling in Liver Development
$396,852Satdarshan Singh Monga · University Of Pittsburgh At Pittsburgh · R01 · FY2011 · DK
Hepatic Tissue Engineering
$396,800Massachusetts General Hospital · R01 · FY2004 · DK
FOCUS Data Coordinating Center
$396,799Maryland Medical Research Institute, Inc · U01 · FY2003 · HL
Role of SH2-B in Glucose Metabolism
$396,795Liangyou Rui · University Of Michigan At Ann Arbor · R01 · FY2010 · DK
Mechanisms of Oval Cell Activation and Differentiation
$396,791Bryon E Petersen · University Of Florida · R01 · FY2012 · DK
Molecular Physiology of Biliary Lipid Secretion
$396,781David E Cohen · Brigham And Women'S Hospital · R01 · FY2006 · DK
Micro Analytical Immunochemistry
$396,765Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2025 · EB
Mechanistic Study of PEG-asparaginase-Induced Liver Injury
$396,750Christian Antonio Fernandez · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Mechanistic Study of PEG-asparaginase-Induced Liver Injury
$396,750Christian Antonio Fernandez · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · DK
Cognitive Enhancement as a Target for Cocaine Pharmacotherapy
$396,743Mehmet Sofuoglu · Yale University · R01 · FY2012 · DA
Mechanisms of hepatitis C virus persistence
$396,734Arash Grakoui · Emory University · R01 · FY2010 · AI
Using the VACS Index to track health outcomes associated with changes in drug use
$396,726David Fiellin · Yale University · R01 · FY2014 · DA